Collectively, our data identify LGP2 as an important sensor of endogenous stimulatory RNA and as an essential player in autoinflammation driven by ADAR1 dysfunction with important implications for treatment of type I interferonopathies as well as for potential ADAR1‐directed cancer therapy. This evidence concerns the gene ADAR and cancer.